Pharming Group (OTCMKTS:PHGUF) Shares Up 10.6% – Here’s Why

Pharming Group (OTCMKTS:PHGUF) shares were up 10.6% during mid-day trading on Wednesday . The stock traded as high as $0.84 and last traded at $0.84. Approximately 2,000 shares were traded during trading, a decline of 38% from the average daily volume of 3,244 shares. The stock had previously closed at $0.76.

Pharming Group Trading Up 10.6 %

The firm has a market cap of $550.63 million, a price-to-earnings ratio of -42.20 and a beta of 1.11. The company’s 50-day moving average price is $0.80 and its 200-day moving average price is $0.81. The company has a quick ratio of 2.76, a current ratio of 3.53 and a debt-to-equity ratio of 0.53.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.